An Acceptor-Donor-Acceptor Structured Small Molecule for Effective NIR Triggered Dual Phototherapy of Cancer

An Acceptor-Donor-Acceptor Structured Small Molecule for Effective NIR Triggered Dual Phototherapy of Cancer
复制标题

用于有效近红外触发癌症双重光疗的受体-供体-受体结构小分子

DOI:
10.1002/adfm.201910301
复制
发表时间:
2020-02-24
影响因子:
19
通讯作者:
Chen, Yongsheng
Chen, Yongsheng
中科院分区:
材料科学1区
文献类型:
--
作者:
He, Zheng;Zhao, Linlin;Chen, Yongsheng

文献摘要

被引文献

相似文献

双重光疗,包括光动力疗法(PDT)和光热疗法(PTT),被认为是一种比单一PDT或PTT更有效的癌症治疗方法。然而,开发用于有效双重光疗的单组分和近红外(NIR)触发剂仍然是一个挑战。本文提出了一种开发用于PDT和PTT联合治疗的双功能小分子光敏剂的简单策略:1)精细地调节HOMO-LUMO能级以调节用于PDT的有效单线态氧(O-1(2))产生的系统间交叉(ISC)过程; 2)通过强的分子内电荷转移(ICT)有效抑制荧光,以最大化用于PTT或用于PDT的ISC过程的光能到热的转化。设计并合成了一种受体-供体-受体(A-D-A)结构的小分子(CPDT)。通过直接用叶酸官能化的两亲性共聚物包封CPDT制备的生物相容性纳米颗粒FA-CNPs在单次808 nm激光照射下表现出强的NIR吸收、稳健的光稳定性、癌细胞靶向、高光热转换效率以及高效的O-1(2)产生。此外,FA-CNP在体内的协同PDT和PTT效应通过显著抑制肿瘤生长来证明。该策略为合理设计和开发安全有效的光敏剂提供了新的途径。
Dual phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is regarded as a more effective method for cancer treatment than single PDT or PTT. However, development of single component and near-infrared (NIR) triggered agents for efficient dual phototherapy remains a challenge. Herein, a simple strategy to develop dual-functional small-molecules-based photosensitizers for combined PDT and PTT treatment is proposed through: 1) finely modulating HOMO-LUMO energy levels to regulate the intersystem crossing (ISC) process for effective singlet oxygen (O-1(2)) generation for PDT; 2) effectively inhibiting fluorescence via strong intramolecular charge transfer (ICT) to maximize the conversion of photo energy to heat for PTT or ISC process for PDT. An acceptor-donor-acceptor (A-D-A) structured small molecule (CPDT) is designed and synthesized. The biocompatible nanoparticles, FA-CNPs, prepared by encapsulating CPDT directly with a folate functionalized amphipathic copolymer, present strong NIR absorption, robust photostability, cancer cell targeting, high photothermal conversion efficiency as well as efficient O-1(2) generation under single 808 nm laser irradiation. Furthermore, synergistic PDT and PTT effects of FA-CNPs in vivo are demonstrated by significant inhibition of tumor growth. The proposed strategy may provide a new approach to reasonably design and develop safe and efficient photosensitizers for dual phototherapy against cancer.